デフォルト表紙
市場調査レポート
商品コード
1434667

解剖学的病理学検査市場:構成要素別、用途別-2024-2030年の世界予測

Anatomic Pathology Testing Market by Component (Consumables, Instruments, Services), Application (Disease Diagnosis, Drug Discovery & Development) - Global Forecast 2024-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 190 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.87円
解剖学的病理学検査市場:構成要素別、用途別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 190 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

解剖学的病理学検査市場規模は2023年に424億3,000万米ドルと推定され、2024年には450億3,000万米ドルに達し、CAGR 6.22%で2030年には647億4,000万米ドルに達すると予測されます。

解剖学的病理学検査の世界市場

主な市場の統計
基準年[2023] 424億3,000万米ドル
予測年[2024] 450億3,000万米ドル
予測年 [2030] 647億4,000万米ドル
CAGR(%) 6.22%
解剖学的病理学検査 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは解剖学的病理学検査市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析は、解剖学的病理学検査市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています:

1-市場の浸透度:主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度:有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化:新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報:市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション:将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています:

1-解剖学的病理学検査市場の市場規模および予測は?

2-解剖学的病理学検査市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か?

3-解剖学的病理学検査市場における技術動向と規制の枠組みは?

4-解剖学的病理学検査市場における主要ベンダーの市場シェアは?

5-解剖学的病理学検査市場への参入に適した形態や戦略的手段は?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 食生活やライフスタイルの変化による抗がん剤の臨床試験件数の増加
      • 個別化医療への注目の高まり
      • 臨床センターでの診断手順を改善する需要が急増
    • 抑制要因
      • 熟練した専門家の不足
    • 機会
      • 解剖学的病理学検査の進歩により、ターゲットを絞ったカバレッジを提供
      • 悪性腫瘍および腫瘍形成を探索するためのバイオマーカーに基づく病理検査および手順への依存の増加
    • 課題
      • 政府による厳格な規則と規制
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 解剖学的病理学検査市場:コンポーネント別

  • 消耗品
  • 機器
  • サービス

第7章 解剖学的病理学検査市場:用途別

  • 病気の診断
  • 創薬と開発

第8章 南北アメリカの解剖学的病理学検査市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の解剖学的病理学検査市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの解剖学的病理学検査市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ主要企業別の分析

第12章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Abbott Laboratories
    • Agilent Technologies Inc.
    • Becton, Dickinson and Company
    • Cardinal Health, Inc.
    • Danaher Corporation
    • Diapath S.p.A.
    • Digipath, Inc.
    • Enzo Biochem, Inc.
    • Epic Sciences
    • Epredia
    • F. Hoffmann-La Roche AG
    • Hologic, Inc.
    • Laboratory Corporation of America Holdings
    • Merck KGaA
    • Quest Diagnostics Incorporated
    • Sakura Finetek USA, Inc.
  • 主要な製品ポートフォリオ

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. ANATOMIC PATHOLOGY TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. ANATOMIC PATHOLOGY TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ANATOMIC PATHOLOGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ANATOMIC PATHOLOGY TESTING MARKET DYNAMICS
  • FIGURE 7. ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 8. ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ANATOMIC PATHOLOGY TESTING MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. ANATOMIC PATHOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ANATOMIC PATHOLOGY TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ANATOMIC PATHOLOGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 6. ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 10. ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 15. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 26. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. AUSTRALIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CHINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. INDIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. INDONESIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. JAPAN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. MALAYSIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. PHILIPPINES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. SINGAPORE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. SOUTH KOREA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. TAIWAN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. THAILAND ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. VIETNAM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. DENMARK ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EGYPT ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. FINLAND ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. ISRAEL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ITALY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. NETHERLANDS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. NIGERIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NORWAY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. POLAND ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. QATAR ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. RUSSIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. SAUDI ARABIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SPAIN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SWEDEN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SWITZERLAND ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. TURKEY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED ARAB EMIRATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ANATOMIC PATHOLOGY TESTING MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 99. ANATOMIC PATHOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. ANATOMIC PATHOLOGY TESTING MARKET LICENSE & PRICING
目次
Product Code: MRR-436901066181

[190 Pages Report] The Anatomic Pathology Testing Market size was estimated at USD 42.43 billion in 2023 and expected to reach USD 45.03 billion in 2024, at a CAGR 6.22% to reach USD 64.74 billion by 2030.

Global Anatomic Pathology Testing Market

KEY MARKET STATISTICS
Base Year [2023] USD 42.43 billion
Estimated Year [2024] USD 45.03 billion
Forecast Year [2030] USD 64.74 billion
CAGR (%) 6.22%
Anatomic Pathology Testing Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Anatomic Pathology Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Anatomic Pathology Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Anatomic Pathology Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies Inc., Becton, Dickinson and Company, Cardinal Health, Inc., Danaher Corporation, Diapath S.p.A., Digipath, Inc., Enzo Biochem, Inc., Epic Sciences, Epredia, F. Hoffmann-La Roche AG, Hologic, Inc., Laboratory Corporation of America Holdings, Merck KGaA, Quest Diagnostics Incorporated, and Sakura Finetek USA, Inc..

Market Segmentation & Coverage

This research report categorizes the Anatomic Pathology Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Component
    • Consumables
    • Instruments
    • Services
  • Application
    • Disease Diagnosis
    • Drug Discovery & Development
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Anatomic Pathology Testing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Anatomic Pathology Testing Market?

3. What are the technology trends and regulatory frameworks in the Anatomic Pathology Testing Market?

4. What is the market share of the leading vendors in the Anatomic Pathology Testing Market?

5. Which modes and strategic moves are suitable for entering the Anatomic Pathology Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Anatomic Pathology Testing Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in the number of clinical trials pertaining to cancer drugs due to changes in food habits and lifestyle
      • 5.1.1.2. Increasing focus on personalized medicine
      • 5.1.1.3. Surge in demand to improve the diagnostic procedure in clinical centers
    • 5.1.2. Restraints
      • 5.1.2.1. Unavailability of skilled professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Advances in anatomic pathology testing providing targeted coverage
      • 5.1.3.2. Growth in reliance on biomarkers-based pathology tests and procedures for exploring malignancy and tumorigenesis
    • 5.1.4. Challenges
      • 5.1.4.1. Strigent rules and regulations by the government
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Anatomic Pathology Testing Market, by Component

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Instruments
  • 6.4. Services

7. Anatomic Pathology Testing Market, by Application

  • 7.1. Introduction
  • 7.2. Disease Diagnosis
  • 7.3. Drug Discovery & Development

8. Americas Anatomic Pathology Testing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Anatomic Pathology Testing Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Anatomic Pathology Testing Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Abbott Laboratories
    • 12.1.2. Agilent Technologies Inc.
    • 12.1.3. Becton, Dickinson and Company
    • 12.1.4. Cardinal Health, Inc.
    • 12.1.5. Danaher Corporation
    • 12.1.6. Diapath S.p.A.
    • 12.1.7. Digipath, Inc.
    • 12.1.8. Enzo Biochem, Inc.
    • 12.1.9. Epic Sciences
    • 12.1.10. Epredia
    • 12.1.11. F. Hoffmann-La Roche AG
    • 12.1.12. Hologic, Inc.
    • 12.1.13. Laboratory Corporation of America Holdings
    • 12.1.14. Merck KGaA
    • 12.1.15. Quest Diagnostics Incorporated
    • 12.1.16. Sakura Finetek USA, Inc.
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing